Strategic Planning

Unprecedented change in the healthcare and life sciences industry today is driving significant challenges and opportunities. As the blockbuster age winds down, a brighter light is shining on specialty markets, value and evidence, and long-term safety. Many factors are driving change, including company consolidation, the coming of age of biosimilars, emerging growth markets, new commercialization models and the empowerment of new stakeholders.

Optimal strategic planning requires many types of analyses, such as evaluating the market potential for developing compounds, identifying and evaluating licensing candidates, or modeling the potential revenue streams of new products. Backed by industry-leading, proprietary databases, Kantar Health delivers a unique blend of scientific and commercial expertise to help you make astute investment decisions that will increase the value of your product throughout the entire lifecycle.

Our services include:

  • Clinical and scientific assessments
  • Market research
  • Epidemiology and forecasting
  • Market access strategies
  • Health economics and outcomes research

Our experts are unparalleled in the healthcare industry in analyzing markets and defining value across all therapeutic categories. In partnership with you, we’ll develop successful strategies to support your strategic growth initiatives.